Welcome to LookChem.com Sign In|Join Free
  • or
The chemical compound "((3aR,4R,6R,6aR)-6-(6-(cyclohexylamino)-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol" is a complex organic molecule with a unique structure. It features a cyclohexylamine group attached to a purine ring, which is a key component of many biologically active molecules, including nucleic acids and certain drugs. The compound also includes a tetrahydrofuro[3,4-d][1,3]dioxol-4-yl group, which is a cyclic structure that contributes to the molecule's overall shape and properties. This specific arrangement of atoms and functional groups suggests that the compound may have potential applications in medicinal chemistry, possibly as a precursor to drugs or as a molecule with biological activity itself. The stereochemistry of the compound, indicated by the 'R' configurations at various positions, is crucial for its potential interactions with biological targets.

3369-66-2

Post Buying Request

3369-66-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3369-66-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3369-66-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,6 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3369-66:
(6*3)+(5*3)+(4*6)+(3*9)+(2*6)+(1*6)=102
102 % 10 = 2
So 3369-66-2 is a valid CAS Registry Number.

3369-66-2Relevant academic research and scientific papers

METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION

-

, (2016/06/28)

The present invention is directed to selective adenosine A1 agonist compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, reduce or prevent age-related macular degeneration.

METHOD OF PROVIDING OCULAR NEUROPROTECTION

-

Paragraph 0166, (2014/09/30)

Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for preventing, reducing or treating retinal ganglion cell damage comprising administering an effective amount of a purine deri

METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS

-

Page/Page column 31, (2010/11/17)

Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3369-66-2